CYP46A1 activation by low-dose efavirenz enhances brain cholesterol metabolism in subjects with early Alzheimer’s disease

被引：0
|
作者：
Alan J. Lerner
Steven E. Arnold
Erin Maxfield
Aaron Koenig
Maria E. Toth
Brooke Fortin
Natalia Mast
Bianca A. Trombetta
John Denker
Andrew A. Pieper
Curtis Tatsuoka
Sangeetha Raghupathy
Irina A. Pikuleva
机构：
[1] Brain Health and Memory Center,Department of Neurology
[2] Neurological Institute,Alzheimer’s Clinical and Translational Research Unit
[3] University Hospitals Cleveland Medical Center,Department of Ophthalmology and Visual Sciences
[4] Case Western Reserve University,Harrington Discovery Institute
[5] Massachusetts General Hospital,Department of Psychiatry
[6] Case Western Reserve University,Institute for Transformative Molecular Medicine, School of Medicine
[7] University Hospitals Cleveland Medical Center,Department of Population and Quantitative Health Sciences
[8] Case Western Reserve University,undefined
[9] Geriatric Psychiatry,undefined
[10] GRECC,undefined
[11] Louis Stokes Cleveland VA Medical Center,undefined
[12] Case Western Reserve University,undefined
[13] Case Western Reserve University,undefined
来源：
Alzheimer's Research & Therapy | / 14卷
关键词：
CYP46A1; Efavirenz; Alzheimer’s disease; 24-Hydroxycholesterol; Stable isotope labeling kinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] CYP46A1 activation by low-dose efavirenz enhances brain cholesterol metabolism in subjects with early Alzheimer's disease
    Lerner, Alan J.
    Arnold, Steven E.
    Maxfield, Erin
    Koenig, Aaron
    Toth, Maria E.
    Fortin, Brooke
    Mast, Natalia
    Trombetta, Bianca A.
    Denker, John
    Pieper, Andrew A.
    Tatsuoka, Curtis
    Raghupathy, Sangeetha
    Pikuleva, Irina A.
    ALZHEIMERS RESEARCH & THERAPY, 2022, 14 (01)
  • [2] CYP46A1 variants influence Alzheimer's disease risk and brain cholesterol metabolism
    Koelsch, Heike
    Luetjohann, Dieter
    Jessen, Frank
    Popp, Julius
    Hentschel, Frank
    Kelemen, Peter
    Schmitz, Sandra
    Maier, Wolfgang
    Heun, Reinhard
    EUROPEAN PSYCHIATRY, 2009, 24 (03) : 183 - 190
  • [3] Investigating the Effects of Brain Cholesterol Metabolism Using CYP46A1 Gene Therapy in Subjects with Huntington's Disease
    Schultz, Meredith
    Durr, Alexandra
    Karachi, Carine
    O'Callaghan, Michael
    Alves, Sandro
    Lamontagne, Alain
    Hurmic, Hortense
    Cartier, Nathalie
    NEUROLOGY, 2023, 100 (17)
  • [4] CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer's disease
    Djelti, Fathia
    Braudeau, Jerome
    Hudry, Eloise
    Dhenain, Marc
    Varin, Jennifer
    Bieche, Ivan
    Marquer, Catherine
    Chali, Farah
    Ayciriex, Sophie
    Auzeil, Nicolas
    Alves, Sandro
    Langui, Dominique
    Potier, Marie-Claude
    Laprevote, Olivier
    Vidaud, Michel
    Duyckaerts, Charles
    Miles, Richard
    Aubourg, Patrick
    Cartier, Nathalie
    BRAIN, 2015, 138 : 2383 - 2398
  • [5] CYP46A1 gene therapy deciphers the role of brain cholesterol metabolism in Huntington's disease
    Kacher, Radhia
    LamaziEre, Antonin
    Heck, Nicolas
    Kappes, Vincent
    Mounier, Coline
    Despres, GaEtan
    Dembitskaya, Yulia
    Perrin, Elodie
    Christaller, Wilhelm
    Nair, Satish Sasidharan
    Messent, ValErie
    Cartier, Nathalie
    Vanhoutte, Peter
    Venance, Laurent
    Saudou, FrEdEric
    NEri, Christian
    Caboche, Jocelyne
    Betuing, Sandrine
    BRAIN, 2019, 142 : 2432 - 2450
  • [6] Modulation of Brain Cholesterol Metabolism through CYP46A1 Overexpression for Rett Syndrome
    Audouard, Emilie
    Khefif, Nicolas
    Gillet-Legrand, Beatrix
    Nobilleau, Fanny
    Bouazizi, Ouafa
    Stanga, Serena
    Despres, Gaetan
    Alves, Sandro
    Lamaziere, Antonin
    Cartier, Nathalie
    Piguet, Francoise
    PHARMACEUTICS, 2024, 16 (06)
  • [7] Modulation of brain cholesterol metabolism through CYP46A1 overexpression for Rett syndrome
    Audouard, E.
    Nobilleau, F.
    Bouazizi, O.
    Stanga, S.
    Lamaziere, A.
    Meha, B.
    Cartier, N.
    Piguet, F.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A44 - A44
  • [8] Metabolism of oral turinabol by the human brain cholesterol 24-hydroxylase CYP46A1
    Putkaradze, Natalia
    Hartz, Philip
    Hutter, Michael C.
    Zapp, Josef
    Thevis, Mario
    Bernhardt, Rita
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2021, 212
  • [9] Unbiased insights into the multiplicity of the CYP46A1 brain effects in 5XFAD mice treated with low dose-efavirenz
    Mast, Natalia
    Butts, Makaya
    Pikuleva, Irina A.
    JOURNAL OF LIPID RESEARCH, 2024, 65 (06)
  • [10] Polymorphisms of the cholesterol 24-hydroxylase (CYP46A1) gene and the risk of Alzheimer's disease in a Chinese population
    Ma, Suk Ling
    Tang, Nelson Leung Sang
    Lam, Linda Chiu Wa
    Chiu, Helen Fung Kum
    INTERNATIONAL PSYCHOGERIATRICS, 2006, 18 (01) : 37 - 45
12345